Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,077.7
-22.6 (-0.73%)

 

  • STI Straits Times Index
    3,077.7
    -22.6 (-0.73%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,546.8
    13.8 (0.90%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,500.4
    291.6 (1.20%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,602.2
    19.4 (0.54%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,184.0
    -56.1 (-0.19%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,113.1
    -9.4 (-0.15%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,534.8M
  • Value: 1,266.0M
  • Rise: 150
  • Fall: 179
  • Unch: 426

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.082+0.001
FJ Benjamin0.030+0.004
RH PetroGas0.157+0.022
Hatten Land0.061+0.006
Rex Intl0.215+0.015
Blumont0.005-
Singtel2.480-0.030
Genting Sing0.720-0.025
YZJ Shipbldg SGD1.390-0.010
ThaiBev0.655-

World Indices

World Indices
Name Last Change
Nasdaq 14,970.0 -77.7
HSI 24,500.4 +291.6
HSCEI 8,720.3 +136.5
Jakarta 6,113.1 -9.4
Nikkei 225 30,184.0 -56.1
SSE Comp 3,602.2 +19.4
Shanghai A 3,775.3 +20.3
Shanghai B 274.8 +3.7
KOSPI 3,097.9 -35.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PFIZER INC PFIZER
Updated on 27 Sep 2021 (End of trading day)
Last (USD): 43.570 Change: -0.370 High: 44.130 Remarks: -
Change (%): -0.84 Low: 43.510
Open 43.920 Yesterday's Close 43.94
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 19,936,150 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.71509 Trailing EPS (USD) e 2.35932 NAV (USD) b 12.4926
PE a 25.404 Trailing PE f 18.467 Price / NAV b 3.4877
Dividend (USD) d 1.519169 Cash In Hand (USD) g 0.4231 Issued & Paid-up Shares c 5,606,690,000
Dividend Yield (%) d 3.487 Price / Cash In Hand g 102.978 Treasury Shares h 3,851,000,000
Market Cap (M) 244,283.483 Enterprise Value (M) 262,098.483
Piotroski F Score 4 Exchange Code PFE Par Value ( $ ) n.a.
52 Weeks Volatility (%) 23.11 Free Float (%) -
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 13 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 May 2021.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PFIZER INC NYSE 244,283.483 25.404 18.467 3.4877 3.487
Industry Pharmaceuticals: Major NYSE 114,838.683 32.749 27.488 5.3973 2.842
Local Peer JOHNSON & JOHNSON NYSE 429,541.762 29.193 24.176 6.1734 2.439
Local Peer ELI LILLY AND COMPANY NYSE 216,569.938 34.966 35.675 33.6060 1.307
Local Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 201,058.748 24.760 22.354 3.7204 2.334
Local Peer ABBVIE INC NYSE 190,360.630 41.782 28.891 15.1452 4.488
Local Peer MERCK & CO INC NYSE 185,701.303 26.277 33.334 5.5776 3.379
Local Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 175,625.245 27.255 24.670 16.7981 1.358
Local Peer BRISTOL-MYERS SQUIBB CO NYSE 132,971.062 - - 3.6126 3.105
Local Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 96,860.995 13.139 16.331 4.5598 5.374
Local Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 53,828.315 15.183 13.330 1.1405 4.504
Local Peer BIOHAVEN PHARMACEUTICAL HLDG CO LTD NYSE 8,690.511 - - -19.1472 -
Local Peer ORGANON & CO NYSE 8,503.899 3.937 3.937 -4.3971 -
Local Peer EMERGENT BIOSOLUTIONS INC NYSE 2,869.765 9.406 9.591 1.8590 -
Other Local Peers ADC THERAPEUTICS SA (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), ZYMEWORKS INC (NYSE), LANNETT CO INC (NYSE)
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 181,929.827 56.924 48.244 11.6057 1.977
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 121,595.872 8.662 17.559 1.6214 2.779
Global Peer WUXI APPTEC HKEx 535,703.618 161.407 115.681 12.1346 0.194
Global Peer ROYALTY PHARMA PLC NASDAQ 22,556.440 23.134 23.218 3.9340 0.516
Global Peer REPLIGEN CORP NASDAQ 16,898.342 281.986 169.097 10.5412 -
Global Peer VIATRIS INC NASDAQ 16,712.388 - - 0.7881 -
Global Peer HANSOH PHARMA HKEx 112,050.862 38.817 36.262 4.9807 0.407
Global Peer INNOVENT BIO HKEx 110,850.560 - - 7.7470 -
Global Peer CANSINOBIO-B HKEx 93,872.748 - 119.192 11.1318 -
Global Peer CUREVAC NV NASDAQ 10,463.702 - - - -
Other Global Peers ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), SINOPHARM (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), REMEGEN-B (HKEx), HUTCHMED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), ALLAKOS INC (NASDAQ), SH PHARMA (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), JUNSHI BIO (HKEx), HYGEIA HEALTH (HKEx), AKESO-B (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), CMS (HKEx), BAIYUNSHAN PH (HKEx), IMMUNITYBIO INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), INNOCARE-B (HKEx), CARSGEN-B (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), SIMCERE PHARMA (HKEx), ERASCA INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), TRAD CHI MED (HKEx), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), EVEREST MED-B (HKEx), QUANTERIX CORPORATION (NASDAQ), HENLIUS (HKEx), CSTONE PHARMA-B (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SSY GROUP (HKEx), HEPALINK (HKEx), OCUMENSION-B (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), KRONOS BIO INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), UNITED LAB (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ICOSAVAX INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), FULCRUM THERAPEUTICS INC (NASDAQ), TONGRENTANGCM (HKEx), FORMA THERAPEUTICS HLDGS INC (NASDAQ), IMMUNOTECH-B (HKEx), REPARE THERAPEUTICS INC (NASDAQ), GH RESEARCH PLC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), Kimia Farma Tbk. (IDX), ORIC PHARMACEUTICALS INC (NASDAQ), SCICLONE PHARMA (HKEx), GOSSAMER BIO INC (NASDAQ), CKLIFE SCIENCES (HKEx), PRAXIS PRECISION MEDICINES INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ANTENGENE-B (HKEx), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ANNEXON INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), TENAYA THERAPEUTICS INC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), VERU INC (NASDAQ), PETIQ INC (NASDAQ), SHINEWAY PHARM (HKEx), ALIGOS THERAPEUTICS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), PHARVARIS NV (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), BEYONDSPRING INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), HUA MEDICINE-B (HKEx), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), ZHAOKE OPHTH-B (HKEx), SIGA TECHNOLOGIES INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), AC IMMUNE SA (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), Soho Global Health Tbk. (IDX), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), CLENE INC (NASDAQ), EVOLUS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), IGBB (Bursa), 89BIO INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), RACE ONCOLOGY LTD (ASX), SILVERBACK THERAPEUTICS INC (NASDAQ), CYBIN INC (NYSE American), NEXIMMUNE INC (NASDAQ), ESSA PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), ATHENEX INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), TOT BIOPHARM-B (HKEx), PYC THERAPEUTICS LIMITED (ASX), OYSTER POINT PHARMA INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), INOZYME PHARMA INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), DAWNRAYS PHARMA (HKEx), AFT PHARMACEUTICALS LTD (ASX), IMPEL NEUROPHARMA INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), ANNOVIS BIO INC (NYSE American), CHECKPOINT THERAPEUTICS INC (NASDAQ), XOMA CORP (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), BSTEAD (Bursa), OBSEVA SA (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), VINCERX PHARMA INC (NASDAQ), HARROW HEALTH INC (NASDAQ), PHARMA (Bursa), MUSTANG BIO INC (NASDAQ), IMMUNIC INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), FUSEN PHARM (HKEx), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), TRICIDA INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), IP (SET), KALA PHARMACEUTICALS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), CH BIOTECH SER (HKEx), XERIS PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), NOVAN INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ENTERA BIO LTD (NASDAQ), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), GENPREX INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), IX Biopharma (SGX), ZHONGZHIPHARM (HKEx), EYENOVIA INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), NOXOPHARM LTD (ASX), ODONATE THERAPEUTICS INC (NASDAQ), IMARA INC (NASDAQ), Merck Tbk. (IDX), YUMANITY THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), CHARMACY PHAR (HKEx), APREA THERAPEUTICS INC (NASDAQ), KOTRA (Bursa), CRESO PHARMA LTD (ASX), ELEDON PHARMACEUTICALS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), NEW RAY MEDIC (HKEx), OCUPHIRE PHARMA INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), GRAYBUG VISION INC (NASDAQ), PROPHASE LABS INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), SANAI HEALTH GP (HKEx), ALLENA PHARMACEUTICALS INC (NASDAQ), Phapros Tbk. (IDX), NC HEALTHCARE (HKEx), PAK FAH YEOW (HKEx), MANNATECH INC (NASDAQ), EXOPHARM LTD (ASX), NOVA (Bursa), Hyphens Pharma (SGX), BIOHLDG (Bursa), BRICKELL BIOTECH INC (NASDAQ), ABVC BIOPHARMA INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), RENOVORX INC (NASDAQ), MODERN CHI MED (HKEx), INVION LTD (ASX), SYNAPTOGENIX INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), NEP INTERLONG (HKEx), BAUDAX BIO INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), WAI YUEN TONG (HKEx), SEQLL INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PHARMAXIS (ASX), ASSERTIO HOLDINGS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), PURAPHARM (HKEx), PASITHEA THERAPEUTICS CORP (NASDAQ), MEDLAB CLINICAL LIMITED (ASX), AGEX THERAPEUTICS INC (NYSE American), ACER THERAPEUTICS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), JCT (SET), SUNZEN (Bursa), EXTRAWELL PHAR (HKEx), TREVI THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), PALLA PHARMA LTD (ASX), PANBELA THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ACRUX (ASX), IMMURON LIMITED (ASX), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), TITAN PHARMACEUTICAL INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), SINOLIFE UTD (HKEx), CHINA SXT PHARMACEUTICALS INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.350
-0.80 %
10 Days --1.140
-2.55 %
20 Days --2.500
-5.43 %
Medium Term Return 3 Months -+4.470
+11.43 %
6 Months -+7.460
+20.66 %
1 Year 39.910+7.400
+130.80 %
Long Term Return 2 Years 100.690+8.140
+307.17 %
3 Years 102.110-0.650
+229.44 %
5 Years 104.710+9.850
+339.74 %
Annualised Return Annualised --
+34.47 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 33.360 - 51.860 Change From 1 Year Low +10.210 % Change From 1 Year Low (%) +30.61
Change From 1 Year High -8.290 % Change From 1 Year High (%) -15.99
2 Years Range 27.880 - 51.860 Change From 2 Years Low +15.690 % Change From 2 Years Low (%) +56.28
Change From 2 Years High -8.290 % Change From 2 Years High (%) -15.99
5 Years Range 27.880 - 51.860 Change From 5 Years Low +15.690 % Change From 5 Years Low (%) +56.28
Change From 5 Years High -8.290 % Change From 5 Years High (%) -15.99
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
27 Sep 2021 43.920 44.130 43.510 43.570 19,936,150 -
24 Sep 2021 44.070 44.410 43.810 43.940 16,122,840 -
23 Sep 2021 44.280 44.719 44.150 44.190 19,677,730 -
22 Sep 2021 43.990 44.390 43.830 43.950 22,479,730 -
21 Sep 2021 44.250 44.730 43.850 43.920 23,621,470 -
20 Sep 2021 43.390 44.650 43.390 44.200 41,847,860 -
17 Sep 2021 44.170 44.460 43.310 43.890 56,347,130 -
16 Sep 2021 44.880 44.990 44.030 44.470 22,384,720 -
15 Sep 2021 44.560 45.365 44.470 44.770 28,649,150 -
14 Sep 2021 44.670 45.260 44.545 44.710 24,078,970 -
13 Sep 2021 45.740 45.830 44.200 44.580 37,060,600 -
10 Sep 2021 46.270 46.350 45.510 45.590 20,767,210 -
09 Sep 2021 46.470 46.718 45.850 46.030 21,611,480 -
08 Sep 2021 46.510 46.790 46.250 46.510 15,825,610 -
07 Sep 2021 46.990 47.500 46.540 46.750 26,193,820 -
03 Sep 2021 46.900 47.030 46.343 46.840 20,812,390 -
02 Sep 2021 46.480 46.870 46.130 46.840 26,093,310 -
01 Sep 2021 46.190 46.260 45.420 46.040 32,802,450 -
31 Aug 2021 46.720 47.140 45.932 46.070 34,515,470 -
30 Aug 2021 46.200 47.160 46.160 46.760 25,749,690 -
27 Aug 2021 47.370 47.500 46.530 46.600 32,850,340 -
26 Aug 2021 47.700 48.160 47.300 47.380 28,941,370 -
Summary
Current 2 Weeks
(14 Sep 2021 to 27 Sep 2021)
44.670 45.365 43.310 43.570 275,145,750 -
Previous 2 Weeks
(30 Aug 2021 to 13 Sep 2021)
46.200 47.160 43.310 44.580 261,432,030 -
4 Weeks from
(02 Aug 2021 to 27 Aug 2021)
43.300 45.365 43.250 46.600 945,132,310 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.